TrialArthritis & rheumatology (Hoboken, N.J.)2019

Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.

Kenneth G Saag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.